Calendar Pacira BioSciences, Inc.

Equities

PCRX

US6951271005

Market Closed - Nasdaq 01:30:00 27/04/2024 am IST 5-day change 1st Jan Change
26.33 USD +3.25% Intraday chart for Pacira BioSciences, Inc. +0.30% -21.96%

Chart calendar Pacira BioSciences, Inc.

2e22441ee8ae7640b60c8df40419.2wYAAB7YvQJM1QVJXBFkxBxTfXDWuDG21YFduYHsmS0.j2t6a1-x_3thuWd6EngtqUYUKASf1UTphMcy8rDZtB2WU1RaVYzQaha5RA~3b08bc7aabb28727bb992b4c3802b401

Upcoming events on Pacira BioSciences, Inc.

01/05/2024 Q1 2024 Earnings Release (Projected)
14/05/2024 RBC Capital Markets Global Healthcare Conference
31/07/2024 Q2 2024 Earnings Release (Projected)
31/10/2024 Q3 2024 Earnings Release (Projected)
27/02/2025 Q4 2024 Earnings Release (Projected)

Past events on Pacira BioSciences, Inc.

08/04/2024 05:30 pm Needham Healthcare Conference
13/03/2024 11:05 pm Barclays Global Healthcare Conference
29/02/2024 07:00 pm Q4 2023 Earnings Call
29/02/2024 06:30 pm Q4 2023 Earnings Release
10/01/2024 09:45 pm JPMorgan Healthcare Conference
29/11/2023 12:30 am Piper Sandler Healthcare Conference
14/11/2023 04:30 pm Jefferies London Healthcare Conference
02/11/2023 06:00 pm Q3 2023 Earnings Call
02/11/2023 05:30 pm Q3 2023 Earnings Release
11/09/2023 04:30 pm H.C. Wainwright Global Investment Conference
02/08/2023 06:00 pm Q2 2023 Earnings Call
02/08/2023 05:30 pm Q2 2023 Earnings Release
13/06/2023 11:30 pm Annual General Meeting
07/06/2023 07:00 pm Jefferies Global Healthcare Conference
17/05/2023 12:35 am RBC Global Healthcare Conference
03/05/2023 06:00 pm Q1 2023 Earnings Call
03/05/2023 05:30 pm Q1 2023 Earnings Release
19/04/2023 07:45 pm Needham Healthcare Conference
15/03/2023 06:30 pm Barclays Global Healthcare Conference
28/02/2023 07:00 pm Q4 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
421
421
0.09%
430
430
0.01%
542
536
0.95%
667
668
-0.21%
675
675
0.06%

694

EBITDA
Million USD
Released
Forecast
Spread
94,9
85,0
11.65%
113
134
-16.1%
204
190
7.49%
213
224
-4.97%
214
216
-0.81%

218

EBIT
Million USD
Released
Forecast
Spread
75,3
71,0
5.99%
99,3
100
-0.89%
189
175
8.12%
195
204
-4.54%
198
199
-0.53%

195

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-10,7
-1,50
-615.58%
20,1
29,6
-32.06%
56,4
110
-48.5%
13,3
52,5
-74.69%
61,7
54,1
14.07%

84,5

Net income
Million USD
Released
Forecast
Spread
-11,0
-0,28
-3768.66%
146
152
-4.22%
42,0
71,2
-41.05%
15,9
41,9
-62%
42,0
39,6
5.87%

60,4

EPS
USD
Released
Forecast
Spread
-0,27
-0,01
-3500%
3,33
3,41
-2.35%
0,92
1,59
-42.21%
0,34
0,84
-59.4%
0,89
0,79
12.19%

1,22

Announcement Date20/02/2025/02/2124/02/2228/02/2329/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
159
157
1.13%
158
155
1.88%
169
169
0.08%
167
168
-0.03%
172
173
-0.79%
160
159
0.58%
169
175
-3.15%
164
173
-5.2%
181
181
0.21%

166


173


172


183


189

EBITDA
Million USD
Released
Forecast
Spread
69,3
50,8
36.59%
53,8
60,2
-10.51%
44,9
65,5
-31.46%
55,2
64,4
-14.17%
58,8
69,1
-15.01%
41,9
50,1
-16.3%
54,3
60,7
-10.59%
52,9
57,4
-7.76%
65,4
63,2
3.51%

46,2


52,8


51,3


60,8


61,8

EBIT
Million USD
Released
Forecast
Spread
64,0
48,6
31.6%
49,2
53,9
-8.71%
40,9
58,0
-29.48%
50,8
56,9
-10.81%
54,0
61,4
-12.11%
37,4
44,6
-16.05%
50,3
52,8
-4.79%
49,2
51,5
-4.32%
60,7
60,1
1.06%

43,6


48,8


46,2


55,0


59,2

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-6,20
34,1
-118.18%
7,29
26,2
-72.21%
22,0
33,1
-33.47%
2,07
25,1
-91.76%
-18,1
21,2
-185.32%
-26,5
9,47
-379.5%
37,9
19,0
99.64%
16,6
22,8
-27.26%
33,7
26,1
29.15%

20,5


23,1


20,2


20,7


27,5

Net income
Million USD
Released
Forecast
Spread
-5,13
22,7
-122.58%
6,83
22,2
-69.23%
19,9
24,1
-17.62%
-0,69
17,8
-103.88%
-10,1
15,9
-163.73%
-19,5
6,84
-385.81%
25,8
11,0
133.52%
10,9
16,5
-34.02%
24,9
19,8
25.32%

13,7


16,1


14,2


16,4


20,6

EPS
USD
Released
Forecast
Spread
-0,12
0,59
-120.25%
0,15
0,43
-65.44%
0,40
0,50
-20.4%
-0,02
0,35
-105.71%
-0,22
0,32
-169.29%
-0,43
0,14
-418.52%
0,51
0,23
119.35%
0,23
0,33
-29.77%
0,50
0,39
26.9%

0,24


0,31


0,27


0,37


0,38

Announcement Date24/02/2204/05/2203/08/2203/11/2228/02/2303/05/2302/08/2302/11/2329/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PCRX Stock
  4. Calendar Pacira BioSciences, Inc.